KMT2A and acute myeloid leukemia: MYB expression is essential for the initiation and maintenance of MLL-fusion induced AML, and indeed these leukaemias are particularly sensitive to MYB inhibition when compared to normal haematopoietic cells and leukaemias induced by several other oncogenes11–13.